TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biolin Scientific AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
139,760
|
142,469
|
111,700 |
| Financial expenses |
419
|
479
|
438 |
| Earnings before taxes |
4,204
|
24,156
|
19,651 |
| EBITDA |
10,712
|
27,352
|
24,612 |
| Total assets |
153,276
|
144,387
|
115,321 |
| Current assets |
60,229
|
51,048
|
34,409 |
| Current liabilities |
33,250
|
29,852
|
26,443 |
| Equity capital |
118,965
|
113,492
|
88,099 |
| - share capital |
27,413
|
26,927
|
25,143 |
| Employees (average) |
22
|
24
|
21 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
77.6%
|
78.6%
|
76.4% |
| Turnover per employee |
6,353
|
5,936
|
5,319 |
| Profit as a percentage of turnover |
3.0%
|
17.0%
|
17.6% |
| Return on assets (ROA) |
3.0%
|
17.1%
|
17.4% |
| Current ratio |
181.1%
|
171.0%
|
130.1% |
| Return on equity (ROE) |
3.5%
|
21.3%
|
22.3% |
| Change turnover |
-5,277
|
22,843
|
10,549 |
| Change turnover % |
-4%
|
19%
|
10% |
| Chg. No. of employees |
-2
|
3
|
-2 |
| Chg. No. of employees % |
-8%
|
14%
|
-9% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.